Skip to content
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS

Dr. Mark Poznansky Joins The Daily Edition

  • Posted on May 27, 2021

First doses of the COVID-19 vaccines are now quickly rolling out across Canada and in light of recent news, Mass General Hospital’s Dr. Mark Poznansky discusses the topic of mixing and matching vaccines, and what the future of a COVID-19 booster shot could look like. Listen to the full @SXMCanadaTalks interview with host Matt Gurney here: https://soundcloud.com/canadatalks/dr-mark-poznansky-joins-the-daily-edition-with-matt-gurney

CanadaTalks SiriusXM 167 · Dr. Mark Poznansky Joins The Daily Edition
Listen Via Sound Cloud
FacebookTwitter

Recommended Posts

Restoring p53 function with mRNA nanoparticles and immune checkpoint blockade to enhance immunotherapy
181 Nobel Laureates condemn Vladimir Putin’s unprovoked and brutal invasion of Ukraine.
Exciting research reveals new potential in investigating “hybrid immunity” against Covid-19 and evolving variant
Three pillars of pandemic preparedness to end this one while preparing for the next
Vaccine & Immunotherapy Center
Accelerating discovery and development of new products addressing unmet clinical need.
Facebook-f Twitter Youtube

INFORMATION

  • CAREERS
  • Directions
  • Advisors
  • Management
  • Collaborators
  • Support VIC

CONTACT

149 13th Street, 5th Floor
Charlestown Navy Yard,
MA 02129-2020

Phone  :  1-617-643-2098
Email    :  VIC@partners.org

© 2023 VACCINE & IMMUNOTHERAPY CENTER. ALL RIGHTS RESERVED |  Site by OLP